PHGUF (PHGUF) Stock Price & Analysis
PHGUF (PHGUF) rose 0.00% to USD 1.3 as of July 26, 2026 at 08:21 UTC, according to Nexqual real-time market data.
PHGUF last closed at USD 1.3; the session ranged USD 1.18–1.2 on volume of 500 shares. Market capitalization is $1.01B, with a 52-week range of USD 1.14–2.17 (PNK). Source: Nexqual, July 26, 2026 at 08:21 UTC.
Key Statistics (as of July 26, 2026 at 08:21 UTC)
| Price | USD 1.3 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.3 |
| Open | USD 1.2 |
| Day Range | USD 1.18 – 1.2 |
| 52-Week Range | USD 1.14 – 2.17 |
| Volume | 500 shares |
| Market Cap | $1.01B |
| Exchange | PNK |
Technical Analysis (PHGUF)
Nexqual's technical model rates PHGUF "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 26, 2026 at 08:21 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 80.57 (overbought) |
| vs SMA50 | Above (USD 1.24) |
| MACD | 0.02 (positive) |
Analyst Ratings (PHGUF)
Wall Street analysts rate PHGUF "None", per Nexqual as of July 26, 2026 at 08:21 UTC.
| Consensus Rating | None |
|---|
Earnings (PHGUF)
| Next Earnings Date | 2026-07-30 |
|---|---|
| Revenue Estimate | $99.52M |
Source: Nexqual, July 26, 2026 at 08:21 UTC.
Financials & Fundamentals (PHGUF)
| Total Revenue | $369.49M |
|---|---|
| Revenue Growth (YoY) | -8.40% |
| Gross Margin | +88.14% |
| Operating Margin | -6.78% |
| Profit Margin | +3.34% |
| ROE | +5.04% |
| Debt / Equity | 43.21 |
| Current Ratio | 2.63 |
| Total Cash | $170.18M |
| Total Debt | $116.20M |
| Free Cash Flow | $59.02M |
Source: Nexqual, July 26, 2026 at 08:21 UTC.
Financial Health Score (PHGUF)
Nexqual rates PHGUF's overall financial health "Solid" across five dimensions, as of July 26, 2026 at 08:21 UTC.
| Growth | Strong — Revenue +27% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 88%, operating -7% |
| Balance Sheet | Strong — $170M cash vs $116M debt, net cash position |
| Cash Flow | Strong — FCF $59M, 16% margin |
| Efficiency | Mixed — ROE 5%, ROA 4.9% |
Ownership (PHGUF)
| Insider Ownership | +2.52% |
|---|---|
| Institutional Ownership | +22.60% |
| Shares Outstanding | 706.25M |
| Float | 732.89M |
Source: Nexqual, July 26, 2026 at 08:21 UTC.
Leadership (PHGUF)
PHGUF is led by Fabrice Chouraqui M.B.A., Ph.D., Pharm.D., CEO & Executive Director, per Nexqual as of July 26, 2026 at 08:21 UTC.
| CEO & Executive Director | Fabrice Chouraqui M.B.A., Ph.D., Pharm.D. |
|---|---|
| Chief Financial Officer | Kenneth Lynard EMBA, M.Sc. (age 57) |
| Medical Director | Magnus Hansson (age 49) |
Major Backers & Investors (PHGUF)
Notable institutional backers of PHGUF include DFA INVESTMENT TRUST CO-The Continental Small Company Series, Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund, SEI INSTITUTIONAL INVESTMENTS TRUST-SIIT World Equity EX-US Fund, according to Nexqual as of July 26, 2026 at 08:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT TRUST CO-The Continental Small Company Series | 0.7% |
| Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund | 0.26% |
| SEI INSTITUTIONAL INVESTMENTS TRUST-SIIT World Equity EX-US Fund | 0.24% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.88% |
| Dimensional Fund Advisors | 0.17% |
Source: Nexqual, July 26, 2026 at 08:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GGIFF | Garibaldi Resources Corp. | USD 0.05 | ▼ 28.57% |
| PTCHF | PureTech Health PLC | USD 1.6 | ▲ 0% |
| IGGGF | IGG INC | USD 0.39 | ▲ 0% |
| DMPZF | Domino's Pizza Australia New Ze | USD 2.4 | ▲ 0% |
| SBMFF | SINO BIOPHARMACEUTICAL | USD 0.64 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 08:21 UTC. This page is informational and not investment advice.